Literature DB >> 8043445

Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors.

G Socié1, F Sélimi, L Sedel, J Frija, A Devergie, H Esperou Bourdeau, P Ribaud, E Gluckman.   

Abstract

In the present study we describe the incidence, clinical course, and management of avascular necrosis of bone following allogeneic bone marrow transplantation, and identify risk factors related to its development. All patients developing avascular necrosis of bone after allogeneic bone marrow transplantation between January 1974 and September 1992 were included in the analysis and were studied using the Hôpital Saint Louis Bone Marrow Transplant Database and hospital records. 27/727 allogeneic transplant recipients developed avascular necrosis leading to an 8.1% incidence at 5 years, by product limit estimate, ranging from 5% to 11.2%. Symptoms developed 119-1747 d (median 398 d) after transplantation. In these 27 patients a total of 52 joints were affected (mean 1.92 per patient, range 1-7). The hip joint was most often affected (69% of patients). All patients had joint pain that led to diagnosis by means of standard radiographs with or without the help of technetium-99 scans and/or magnetic resonance imaging. All but three patients received steroid therapy for acute graft-versus-host disease. Among 10 factors tested, three were shown to be significantly linked to an increased risk for developing avascular necrosis by multivariate analysis: male gender (relative risk (RR) 4.72, P = 0.002), age older than 16 (RR = 3.87, P = 0.004), and acute graft-versus-host disease requiring steroid therapy (RR = 6.30, P = 0.0002). 10 patients (37%) required joint replacement within 19 months (range 2-42) following diagnosis of avascular necrosis. In conclusion, avascular necrosis of bone is a frequent late complication of allogeneic bone marrow transplantation causing significant morbidity and requiring replacement surgery in one-third of affected patients. In this 18-year single-centre survey, older age, male gender and steroid therapy given for acute graft-versus-host disease were shown to independently increase the risk of avascular necrosis of bone.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043445     DOI: 10.1111/j.1365-2141.1994.tb04795.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.

Authors:  Christopher C Dvorak; Clarisa R Gracia; Jean E Sanders; Edward Y Cheng; K Scott Baker; Michael A Pulsipher; Anna Petryk
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-17       Impact factor: 5.742

Review 2.  Survivorship after allogeneic transplantation-management recommendations for the primary care provider.

Authors:  André Tichelli; Alicia Rovó
Journal:  Curr Hematol Malig Rep       Date:  2015-03       Impact factor: 3.952

Review 3.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

4.  Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning.

Authors:  Johanna Konopacki; Raphaël Porcher; Marie Robin; Sabine Bieri; Jean-Michel Cayuela; Jérôme Larghero; Aliénor Xhaard; Anna Lisa Andreoli; Nathalie Dhedin; Anna Petropoulou; Paula Rodriguez-Otero; Patricia Ribaud; Hélène Moins-Teisserenc; Maryvonnick Carmagnat; Antoine Toubert; Yves Chalandon; Gérard Socie; Régis Peffault de Latour
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

5.  Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation.

Authors:  Stephanie Campbell; Can-Lan Sun; Seira Kurian; Liton Francisco; Andrea Carter; Sameer Kulkarni; Pablo Parker; Chatchada Karanes; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

6.  Osteonecrosis after allogeneic bone marrow transplantation.

Authors:  Frederic Zadegan; Agnes Raould; Pascal Bizot; Remy Nizard; Laurent Sedel
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

7.  Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood.

Authors:  Pauline Girard; Pascal Auquier; Vincent Barlogis; Audrey Contet; Maryline Poiree; François Demeocq; Julie Berbis; Iris Herrmann; Virginie Villes; Nicolas Sirvent; Justyna Kanold; Pascal Chastagner; Hervé Chambost; Dominique Plantaz; Gérard Michel
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

8.  Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging.

Authors:  S Sharma; W-H Leung; P Deqing; J Yang; R Rochester; L Britton; M D Neel; K K Ness; S C Kaste
Journal:  Bone Marrow Transplant       Date:  2011-12-12       Impact factor: 5.483

9.  Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT.

Authors:  S Sharma; S Yang; R Rochester; L Britton; W H Leung; J Yang; M D Neel; K K Ness; S C Kaste
Journal:  Bone Marrow Transplant       Date:  2010-09-06       Impact factor: 5.483

10.  The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours.

Authors:  A M Cook; A S Dzik-Jurasz; A R Padhani; A Norman; R A Huddart
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.